Physician

Brian G. Keeffe, M.D.

According to 2025 Medicare claims, Brian Keeffe, M.D. (NPI: 1689664492) practices cardiology in the San Rafael, CA market, with the plurality of this provider's patient population coming from Marin, CA. This provider's primary affiliated billing organization is REGENTS UNIV OF CALIFORNIA UCSF (NPI: 1124439807; TIN: 943281662) and primary practice location at 94945-5061.

Keeffe's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,836 traditional Medicare patients, billed 5,539 HCPCS/CPT codes, and received $329,061 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 9,087 prescription claims across 1,130 beneficiaries totaling $2,185,025 in drug costs, led by Eliquis (Apixaban). 2022 DME data shows 36 claims. Open Payments data shows 4 records totaling $143. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $517,175 to $2,185,025. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $7,359 and ending at $5,976.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,881	4,687	$302,210
2016	1,903	4,383	$278,566
2017	1,832	4,096	$242,601
2018	1,954	4,302	$274,431
2019	2,053	4,438	$276,159
2020	1,867	5,093	$259,962
2021	1,889	4,388	$275,137
2022	1,741	4,006	$285,460
2023	1,782	4,056	$286,050
2024	1,836	5,539	$329,061

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	540	6,171	$517,175
2016	582	6,492	$666,296
2017	617	6,464	$711,556
2018	712	7,094	$900,841
2019	768	7,318	$1,088,723
2020	811	7,259	$1,193,550
2021	892	8,020	$1,588,089
2022	952	8,037	$1,668,730
2023	1,078	8,465	$1,955,702
2024	1,130	9,087	$2,185,025

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	17	$1,192
2016	N/R	22	$1,460
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	35	$1,920
2022	N/R	36	$1,895
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	864	1,436	$101
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	215	410	$99
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	501	508	$55
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	828	1,267	$13
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	278	308	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	751	47,652	$920,702
Repatha Sureclick	Evolocumab	318	20,155	$388,276
Xarelto	Rivaroxaban	139	10,650	$197,618
Jardiance	Empagliflozin	159	9,030	$172,140
Entresto	Sacubitril/Valsartan	93	6,211	$138,171

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$143	E.R. Squibb & Sons, L.L.C.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Brian G. Keeffe, M.D.?

Tedicare shows public-source Medicare data for Brian G. Keeffe, M.D. (NPI 1689664492), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Brian G. Keeffe, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Brian G. Keeffe, M.D.?

Brian G. Keeffe, M.D. is linked to REGENTS UNIV OF CALIFORNIA UCSF (billing NPI 1124439807) in the available physician profile data.

Does Brian G. Keeffe, M.D. have Open Payments data?

Brian G. Keeffe, M.D. has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.